MK-2866
Also known as Ostarine, Enobosarm
The short answer. Most people who report on MK-2866 say it did not help (only 37% of 489 positive). It is most often used for performance: 87% of 252 reports say that improved. We found no human trials on PubMed. The most common complaint is suppression. It is not an approved supplement and carries real risks.
From 789 mentions in total — the rest didn't say how it went and aren't counted.
What MK-2866 does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
No randomized controlled trials in humans found on PubMed. The grade measures how much human research exists — read the conclusions below for what it found. 0 meta-analyses on PubMed ↗ · 0 randomized trials ↗
17 human trials on ClinicalTrials.gov test MK-2866 — 9 completed. See all on ClinicalTrials.gov ↗
- Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt · Muscle Loss, Obesity · 2025
- Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer · Androgen Receptor Positive, Estrogen Receptor Negative · 2022
- Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence · Stress Urinary Incontinence · 2018
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
“Sleep felt marginally better but side effects and unknown long term safety make me cautious.”
“I have experimented with Ostarine and other grey area supplements and felt great but don’t want to risk my long term health.”
“All in all, great compound. Was very suprised I lost fat, as I was on a huge surplus.”
MK-2866 compared
Other options for performance
Sources
- User reports: 789 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate